Core Insights - Mountain Valley MD Holdings Inc. (MVMD) is focused on disciplined execution across its business lines, aiming for measured growth in product development and commercialization [1] Nutraceuticals - MVMD's Quicksome™ technology optimizes molecule delivery in sublingual nutraceutical applications, enhancing efficacy, precise dosing, and dose sparing [2][3] - The company has an exclusive manufacturing and licensing agreement with a U.S.-based GMP production partner to support Quicksome™ formulations [3] - MVMD is advancing its nutraceutical strategy through partnerships, including a novel testosterone formulation for men, expected to launch in the first half of 2026 [5] Agriculture - MVMD is commercializing its Agrarius™ plant signaling technology, which aims to increase crop yields and reduce fertilizer usage [8] - Trials in Brazil have shown that Agrarius-treated citrus orchards achieved over 50% productivity gains and improved resilience to stress [11][12] - The company is also conducting trials in Colombia, demonstrating improved pasture quality and vegetation health [17] Husbandry Animals and Aquatic Species - MVMD's Soluvec™ 1% formulation, utilizing Quicksol™ technology, aims to provide safer administration of ivermectin for husbandry animals and aquatic species [18] - The company has entered into a licensing agreement in Bangladesh for the production and distribution of Soluvec™ products [19] - Despite initial challenges in commercial traction, MVMD is focusing on royalty-based licensing opportunities for Soluvec™ [21][24]